EUVIMEDEUVIMED entdecken
Crossref

Role of interleukin‐6 and endothelin‐1 receptors in enhanced melanocyte dendricity of facial spots and suppression of their ligands by niacinamide and tranexamic acid

T Hakozaki, J Wang, T Laughlin, B Jarrold, W Zhao, M Furue

Journal of the European Academy of Dermatology and Venereology · 2024-01 · 38 (S2) · 3-10

DOI: 10.1111/jdv.19719 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 20.12.2023. Verfasst von T Hakozaki und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Procter & Gamble Company, Mason Business Center, Mason, Ohio, USA. Hauptthemen laut MEDLINE: Hyperpigmentation, Niacinamide, Receptor, Endothelin A, Tranexamic Acid. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: The Procter & Gamble Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hyperpigmented spots are common issues in all ethnicities with a hallmark characteristic of increased melanocyte dendricity.

Objectives

To determine (1) potential receptors and/or cytokines that are involved in increased melanocyte dendricity in multiple facial spot types; (2) treatment effects of skin‐lightening compounds on identified cytokine release from keratinocytes and on dendricity in melanocytes.

Methods

Facial spots (melasma, solar lentigo, acne‐induced post‐inflammatory hyperpigmentation) and adjacent non‐spot skin biopsies were collected from Chinese women (age 20–70). The epidermal supra and basal layers were laser dissected to enrich keratinocyte or melanocyte biology respectively for transcriptome analysis. Melanocyte dendricity was assessed histologically by immunofluorescent staining. Effect of interleukin‐6 (IL‐6) and endothelin‐1 (ET‐1) on melanocyte dendricity and melanosome transfer were assessed in human melanocytes or melanocyte‐keratinocyte co‐culture models. Treatment effects of skin‐lightening compounds (niacinamide, tranexamic acid [TxA], sucrose laurate/dilaurate mixture [SDL]) were assessed on IL‐6 or ET‐1 release from keratinocytes and on dendricity in melanocytes.

Results

Transcriptome analysis revealed IL‐6 receptor and ET‐1 receptor were significantly upregulated compared to the adjacent normal skin, visually confirmed at the protein level through immunostaining. Melanocytes in spot areas are more dendritic than melanocytes in adjacent non‐spot skin. The addition of IL‐6 and ET‐1 to cell culture models increased melanocyte dendricity and melanosome transfer. IL‐6 release was significantly suppressed by niacinamide and its combination, while ET‐1 release was significantly reduced by both niacinamide and TxA. In contrast, SDL acted directly upon melanocytes to reduce dendricity.

Conclusion

Interleukin‐6 and ET‐1 receptors are significantly upregulated in multiple facial spot types. The in vitro testing demonstrated their respective ligands increased melanocyte dendricity. Tested skin‐lightening compounds showed reduction in release of IL‐6/ET‐1 from epidermal keratinocytes and/or inhibition of melanocyte dendricity. This work sheds light on pathophysiological mechanism of facial spots and potential new mechanisms of these skin‐lightening compounds which warrant further human clinical validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperpigmentationNiacinamideReceptor, Endothelin ATranexamic AcidReceptors, Interleukin-6AdultAgedFemaleHumansMiddle AgedYoung AdultEndothelin-1Interleukin-6KeratinocytesMelanocytes

Substanzen

Endothelin-1Interleukin-6NiacinamideReceptor, Endothelin ATranexamic AcidIL6R protein, humanReceptors, Interleukin-6

Autor:innen und Institutionen

  • The Procter & Gamble Company, Mason Business Center, Mason, Ohio, USA.
  • Department of Dermatology, Kyushu University, Fukuoka, Japan.

Förderung

  • The Procter & Gamble Company

Zitieren

APA

Hakozaki, T., Wang, J., Laughlin, T., Jarrold, B., Zhao, W., & Furue, M. (2024). Role of interleukin‐6 and endothelin‐1 receptors in enhanced melanocyte dendricity of facial spots and suppression of their ligands by niacinamide and tranexamic acid. Journal of the European Academy of Dermatology and Venereology, 38(S2), 3-10. https://doi.org/10.1111/jdv.19719

Vancouver

Hakozaki T, Wang J, Laughlin T, Jarrold B, Zhao W, Furue M. Role of interleukin‐6 and endothelin‐1 receptors in enhanced melanocyte dendricity of facial spots and suppression of their ligands by niacinamide and tranexamic acid. Journal of the European Academy of Dermatology and Venereology. 2024;38(S2):3-10. doi:10.1111/jdv.19719

BibTeX
@article{Hakozaki2024,
  author = {Hakozaki, T and Wang, J and Laughlin, T and Jarrold, B and Zhao, W and Furue, M},
  title = {Role of interleukin‐6 and endothelin‐1 receptors in enhanced melanocyte dendricity of facial spots and suppression of their ligands by niacinamide and tranexamic acid},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2024},
  volume = {38},
  number = {S2},
  pages = {3--10},
  doi = {10.1111/jdv.19719}
}
Kostenlos starten →